BRIEF published on 07/29/2025 at 11:05, 4 months 6 days ago Meliodays and Celanese Collaborate on Hormone-Free IUD for Menstrual Pain Hormone-Free IUD Menstrual Pain Relief Meliodays VitalDose Platform Celanese Partnership
PRESS RELEASE published on 07/29/2025 at 11:00, 4 months 6 days ago Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain Meliodays Medical partners with Celanese to develop hormone-free non-contraceptive IUD for menstrual pain relief using VitalDose(R) Drug Delivery Platform Celanese Drug Delivery Menstrual Pain Meliodays Medical IUD
BRIEF published on 03/20/2025 at 09:10, 8 months 15 days ago Meliodays Medical Secures Over EUR 800,000 in Pre-Seed Financing Pre-seed Financing Menstrual Pain Meliodays Medical Local Treatment Innovative Healthcare
PRESS RELEASE published on 03/20/2025 at 09:05, 8 months 15 days ago Meliodays Medical announces the closing of a pre-seed financing round of over EUR 800,000 Meliodays Medical announces successful closure of over EUR 800,000 pre-seed financing round led by capacura GmbH, focusing on new therapy for menstrual pain with hormone-free, local treatment Financing Hormone-free Menstrual Pain Meliodays Medical Pre-seed
Published on 12/05/2025 at 02:35, 4 hours 19 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 54 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 49 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 54 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 24 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 3 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 29 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 39 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 44 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 54 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 9 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 10 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 53 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
